Effects of Estimated Glomerular Filtration Rate on 30-Day Mortality and Postoperative Complications After Total Hip Arthroplasty: A Risk Stratification Instrument

Published:October 09, 2019DOI:https://doi.org/10.1016/j.arth.2019.10.001

      Abstract

      Background

      Chronic kidney disease (CKD) is a relatively common comorbidity that has been shown to adversely affect outcomes in total hip arthroplasty (THA), as well as to increase the procedure's total costs. However, the effect of different stages of kidney disease and the association of estimated glomerular filtration rate (eGFR) with perioperative THA complications are less understood. Therefore, the aims of this study were to investigate the relationships between eGFR, both as a categorical and continuous variable and 30-day outcomes and complications.

      Methods

      The National Surgical Quality Improvement Program database was used to identify 101,925 primary THAs between January 1, 2008, and December 31, 2016. The following outcomes were assessed: 30-day mortality, 30-day major complications, 30-day minor complications, specific complications, and discharge disposition. To evaluate the effect of eGFR status on outcomes and complication, multivariate regression models were created to adjust for differences in patient demographics and comorbidities. In addition, multivariate spline regressions were developed to assess the nonlinear relationships between eGFR as a continuous variable and the outcomes of interest.

      Results

      Our study revealed that as eGFR decreases to <30 mL/min/1.73 m2, there is an increased risk for mortality and nonhome discharge (P < .05). There was an increased risk for any major complication and any minor complication as well as several specific medical complications such as transfusion and myocardial infarction (P < .05) for an eGFR of <60 mL/min/1.73 m2. Patients' eGFR had a nonlinear relationship with mortality (P = .0001), any major complication (P < .001), and any minor complication (P < .001), as well as a number of other specific medical complications. Once the eGFR, <60 mL/min/1.73 m2 the increase was exponential for mortality, major complications, and minor complications. For example, mortality increased of 900% for <15 mL/min/1.73 m2 or on dialysis, 600% for 15 to 30 mL/min/1.73 m2 and 50% for 30 to 60 mL/min/1.73 m2. Similarly, nonlinear relationships were discovered between eGFR and nonhome discharge (P < .001).

      Conclusion

      Patients with lower eGFR, and in particular those with <30 mL/min/1.73 m2, are more likely to sustain medical complications and have 6 to 9 times higher mortality than patients with normal eGFR. THA patients with CKD should be appropriately counseled and advised on the risk of postoperative complications by using eGFR as a screening tool.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and PersonalCorporate R&D Professionals
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Arthroplasty
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Shrader M.W.
        • Schall D.
        • Parvizi J.
        • McCarthy J.T.
        • Lewallen D.G.
        Total hip arthroplasty in patients with renal failure. A comparison between transplant and dialysis patients.
        J Arthroplasty. 2006; 21: 324-329https://doi.org/10.1016/j.arth.2005.07.008
        • Debarge R.
        • Pibarot V.
        • Guyen O.
        • Vaz G.
        • Carret J.P.
        • Bejui-Hugues J.
        [Total hip arthroplasty in patients with chronic renal failure transplant or dialysis].
        Rev Chir Orthop Reparatrice Appar Mot. 2007; 93: 222-227
        • Sunday J.M.
        • Guille J.T.
        • Torg J.S.
        Complications of joint arthroplasty in patients with end-stage renal disease on hemodialysis.
        Clin Orthop Relat Res. 2002; : 350-355https://doi.org/10.1097/00003086-200204000-00040
        • Kuo L.-T.
        • Lin S.-J.
        • Chen C.-L.
        • Yu P.-A.
        • Hsu W.-H.
        • Chen T.-H.
        Chronic kidney disease is associated with a risk of higher mortality following total knee arthroplasty in diabetic patients: a nationwide population-based study.
        Oncotarget. 2017; 8: 100288-100295https://doi.org/10.18632/oncotarget.22215
        • Siddiqi A.
        • White P.B.
        • Etcheson J.I.
        • George N.E.
        • Gwam C.U.
        • Mistry J.B.
        • et al.
        Acute kidney injury after total knee arthroplasty: a clinical review.
        Surg Technol Int. 2017; 31: 243-252
        • Ferguson K.B.
        • Winter A.
        • Russo L.
        • Khan A.
        • Hair M.
        • MacGregor M.S.
        • et al.
        Acute kidney injury following primary hip and knee arthroplasty surgery.
        Ann R Coll Surg Engl. 2017; 99: 307-312https://doi.org/10.1308/rcsann.2016.0324
        • Ckd D.O.F.
        • Graded N.
        Chapter 1: definition and classification of CKD.
        Kidney Int Suppl. 2013; 3: 19-62https://doi.org/10.1038/kisup.2012.64
        • Jamsa P.P.
        • Oksala N.K.J.
        • Eskelinen A.P.
        • Jamsen E.R.
        Chronic kidney diseases among patients undergoing elective arthroplasty: risk groups and the value of serum creatinine.
        J Arthroplasty. 2018; 33: 230-234.e1https://doi.org/10.1016/j.arth.2017.07.050
        • Inker L.A.
        • Schmid C.H.
        • Tighiouart H.
        • Eckfeldt J.H.
        • Feldman H.I.
        • Greene T.
        • et al.
        Estimating glomerular filtration rate from serum creatinine and cystatin C.
        N Engl J Med. 2012; 367: 20-29https://doi.org/10.1056/NEJMoa1114248
        • Kildow B.J.
        • Agaba P.
        • Moore B.F.
        • Hallows R.K.
        • Bolognesi M.P.
        • Seyler T.M.
        Postoperative impact of diabetes, chronic kidney disease, hemodialysis, and renal transplant after total hip arthroplasty.
        J Arthroplasty. 2017; 32: S135-S140.e1https://doi.org/10.1016/j.arth.2017.01.018
        • Ackland G.L.
        • Moran N.
        • Cone S.
        • Grocott M.P.W.
        • Mythen M.G.
        Chronic kidney disease and postoperative morbidity after elective orthopedic surgery.
        Anesth Analg. 2011; 112: 1375-1381https://doi.org/10.1213/ANE.0b013e3181ee8456
        • Miric A.
        • Inacio M.C.S.
        • Namba R.S.
        The effect of chronic kidney disease on total hip arthroplasty.
        J Arthroplasty. 2014; 29: 1225-1230https://doi.org/10.1016/j.arth.2013.12.031
        • Graves A.
        • Yates P.
        • Hofmann A.O.
        • Farmer S.
        • Ferrari P.
        Predictors of perioperative blood transfusions in patients with chronic kidney disease undergoing elective knee and hip arthroplasty.
        Nephrology (Carlton). 2014; 19: 404-409https://doi.org/10.1111/nep.12239
        • Augustin I.D.
        • Yeoh T.Y.
        • Sprung J.
        • Berry D.J.
        • Schroeder D.R.
        • Weingarten T.N.
        Association between chronic kidney disease and blood transfusions for knee and hip arthroplasty surgery.
        J Arthroplasty. 2013; 28: 928-931https://doi.org/10.1016/j.arth.2013.02.004
        • Gharaibeh K.A.
        • Hamadah A.M.
        • Sierra R.J.
        • Leung N.
        • Kremers W.K.
        • El-Zoghby Z.M.
        The rate of acute kidney injury after total hip arthroplasty is low but increases significantly in patients with specific comorbidities.
        J Bone Joint Surg Am. 2017; 99: 1819-1826https://doi.org/10.2106/JBJS.16.01027
        • Kuo F.-C.
        • Lin P.-C.
        • Lu Y.-D.
        • Lee M.S.
        • Wang J.-W.
        Chronic kidney disease is an independent risk factor for transfusion, cardiovascular complication, and thirty-day readmission in minimally invasive total knee arthroplasty.
        J Arthroplasty. 2017; 32: 1630-1634https://doi.org/10.1016/j.arth.2016.12.006
        • Rozell J.C.
        • Courtney P.M.
        • Dattilo J.R.
        • Wu C.H.
        • Lee G.-C.
        Should all patients be included in alternative payment models for primary total hip arthroplasty and total knee arthroplasty?.
        J Arthroplasty. 2016; 31: 45-49https://doi.org/10.1016/j.arth.2016.03.020
        • Rosas S.
        • Sabeh K.G.
        • Buller L.T.
        • Law T.Y.
        • Roche M.W.
        • Hernandez V.H.
        Medical comorbidities impact the episode-of-care reimbursements of total hip arthroplasty.
        J Arthroplasty. 2017; 32: 2082-2087https://doi.org/10.1016/j.arth.2017.02.039
        • Rosas S.
        • Sabeh K.G.
        • Buller L.T.
        • Law T.Y.
        • Kalandiak S.P.
        • Levy J.C.
        Comorbidity effects on shoulder arthroplasty costs analysis of a nationwide private payer insurance data set.
        J Shoulder Elbow Surg. 2017; 26: e216-e221https://doi.org/10.1016/j.jse.2016.11.044
        • Sabeh K.
        • Rosas S.
        • Buller L.
        • Freiberg A.
        • Emory C.
        • Roche M.
        The impact of medical comorbidities on primary total knee arthroplasty reimbursements.
        J Knee Surg. 2019; 32: 475-482https://doi.org/10.1055/s-0038-1651529
      1. NSQIP. American College of Surgeons National Surgical Quality Improvement Program.
        ([accessed 19.08.2019])
        • Cohen M.E.
        • Ko C.Y.
        • Bilimoria K.Y.
        • Zhou L.
        • Huffman K.
        • Wang X.
        • et al.
        Optimizing ACS NSQIP modeling for evaluation of surgical quality and risk: patient risk adjustment, procedure mix adjustment, shrinkage adjustment, and surgical focus.
        J Am Coll Surg. 2013; 217: 336-346.e1https://doi.org/10.1016/j.jamcollsurg.2013.02.027
        • Zhang J.C.
        • Matelski J.
        • Gandhi R.
        • Jackson T.
        • Urbach D.
        • Cram P.
        Can patient selection explain the obesity paradox in orthopaedic hip surgery? An analysis of the ACS-NSQIP registry.
        Clin Orthop Relat Res. 2018; 476: 964-973https://doi.org/10.1007/s11999.0000000000000218
        • Haughom B.D.
        • Basques B.A.
        • Hellman M.D.
        • Brown N.M.
        • Della Valle C.J.
        • Levine B.R.
        Do mortality and complication rates differ between periprosthetic and native hip fractures?.
        J Arthroplasty. 2018; 33: 1914-1918https://doi.org/10.1016/j.arth.2018.01.046
        • Durand W.M.
        • Goodman A.D.
        • Johnson J.P.
        • Daniels A.H.
        Assessment of 30-day mortality and complication rates associated with extended deep vein thrombosis prophylaxis following hip fracture surgery.
        Injury. 2018; 49: 1141-1148https://doi.org/10.1016/j.injury.2018.03.019
        • Klaher S.
        • Levey A.S.
        • Beck G.J.
        • Caggiula A.W.
        • Hunsicker L.
        • Kusek J.W.
        • et al.
        The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease.
        N Engl J Med. 1994; 330: 877-884https://doi.org/10.1056/NEJM199409293311301
        • National Kidney Foundation
        K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, Clasification and Stratification.
        Am J Kidney Dis. 2002; 39: S1-S266https://doi.org/10.1634/theoncologist.2011-S2-45
        • Pulido L.
        • Parvizi J.
        • Macgibeny M.
        • Sharkey P.F.
        • Purtill J.J.
        • Rothman R.H.
        • et al.
        In hospital complications after total joint arthroplasty.
        J Arthroplasty. 2008; 23: 139-145https://doi.org/10.1016/j.arth.2008.05.011
        • Harrell F.E.J.
        rms: Regression modeling strategies. R package version 4.4-0.
        ([Accessed 09/01/2019])
        • Levey A.S.
        • Inker L.A.
        Assessment of glomerular filtration rate in health and disease: a state of the art review.
        Clin Pharmacol Ther. 2017; 102: 405-419https://doi.org/10.1002/cpt.729
        • Levey A.S.
        • Inker L.A.
        • Coresh J.
        GFR estimation: from physiology to public health.
        Am J Kidney Dis. 2014; 63: 820-834https://doi.org/10.1053/j.ajkd.2013.12.006
        • Deegan B.F.
        • Richard R.D.
        • Bowen T.R.
        • Perkins R.M.
        • Graham J.H.
        • Foltzer M.A.
        Impact of chronic kidney disease stage on lower-extremity arthroplasty.
        Orthopedics. 2014; 37: e613-e618https://doi.org/10.3928/01477447-20140626-51
        • Cavanaugh P.K.
        • Chen A.F.
        • Rasouli M.R.
        • Post Z.D.
        • Orozco F.R.
        • Ong A.C.
        Complications and mortality in chronic renal failure patients undergoing total joint arthroplasty: a comparison between dialysis and renal transplant patients.
        J Arthroplasty. 2016; 31: 465-472https://doi.org/10.1016/j.arth.2015.09.003
        • Tan T.L.
        • Kheir M.M.
        • Tan D.D.
        • Filippone E.J.
        • Tischler E.H.
        • Chen A.F.
        Chronic kidney disease linearly predicts outcomes after elective total joint arthroplasty.
        J Arthroplasty. 2016; 31: 175-179.e2https://doi.org/10.1016/j.arth.2016.03.019